405159-59-3
Chemical Structure
Idrabiotaparinux sodium
- CAS No.: 405159-59-3
- Formula:C53H79N4Na9O51S8
- Molecular Weight:2051.62
IUPAC Name: sodium (2S,3S,4S,5R,6R)-6-(((2R,3R,4S,5R,6R)-6-(((2R,3S,4S,5R,6R)-2-carboxylato-4,5-dimethoxy-6-(((2R,3R,4S,5R,6S)-6-methoxy-4,5-bis(sulfonatooxy)-2-((sulfonatooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-4,5-bis(sulfonatooxy)-2-((sulfonatooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3R,4R,5S,6R)-4,5-dimethoxy-3-(6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)-6-((sulfonatooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dimethoxytetrahydro-2H-pyran-2-carboxylate
InChIKey: LJNNVCTYYRPPRZ-GDNXFURLSA-E
SMILES: O=S(O[C@H]([C@H]([C@@H](O[C@@]1([H])[C@@H]([C@H]([C@H](O[C@@]2([H])[C@@H]([C@H]([C@@H](OC)O[C@@H]2COS(=O)(O[Na])=O)OS(=O)(O[Na])=O)OS(=O)(O[Na])=O)O[C@H]1C(O[Na])=O)OC)OC)O[C@@H]3COS(=O)(O[Na])=O)OS(=O)(O[Na])=O)[C@]3([H])O[C@H]4[C@@H]([C@H]([C@@](O[C@@H]5[C@@H]([C@H]([C@H](OC)[C@@H](COS(=O)(O[Na])=O)O5)OC)NC(CCCCCNC(CCCC[C@H]6[C@](N7)([H])[C@](NC7=O)([H])CS6)=O)=O)([H])[C@@H](C(O[Na])=O)O4)OC)OC)(O[Na])=O
Biological Activity: Idrabiotaparinux sodium is a derivative of Idraparinux synthesized with biotin. Idraparinux is a polymethylated synthetic pentasaccharide known to interact with the antithrombin III and act as anticoagulant[1][2].
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Idrabiotaparinux sodium | Idrabiotaparinux sodium is a derivative of Idraparinux synthesized with biotin. Idraparinux is a polymethylated synthetic pentasaccharide known to interact with the antithrombin III and act as anticoagulant. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Harenberg J. Development of idraparinux and idrabiotaparinux for anticoagulant therapy. Thromb Haemost. 2009;102(5):811-815. [Content Brief]
- [2]. Paty I, Trellu M, Destors JM, Cortez P, Boëlle E, Sanderink G. Reversibility of the anti-FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion. J Thromb Haemost. 2010;8(4):722-729. [Content Brief]
Keywords